1-3 of 3
Nan Qin
Close
Sort by
Journal Articles

A Human iPSC Model Reveals Specific Upregulation of Linker Histone H1-0 in ETV6::RUNX1 + Preleukemia and B Cell Precursor Acute Lymphoblastic Leukemia

Vera H Jepsen, Daniel Hein, Daniel Picard, Tobias Lautwein, Rabea Wagener, Nan Qin, Annika Filip, Merja Heinäniemi, Arndt Borkhardt, Ute Fischer
Journal: Blood
Blood (2022) 140 (Supplement 1): 3469–3470.
https://doi.org/10.1182/blood-2022-163564
Published: 2022
Journal Articles

Investigation of New Therapeutic Compounds for Juvenile Myelomonocytic Leukemia Using Induced Pluripotent Stem Cells with Stably Activated Ras Pathway

Lisa Maria Kuhn, Cyrill Schipp, PhD, Daniel Hein, PhD, Bianca Killing, Nan Qin, PhD, Vera H Jepsen, M.Sc., Heinz Ahlert, MSc, BSc, Jasmin Bartl, PhD, Viktoria Marquardt, M.Sc., David Pauck, Kai Völtzke, M.Sc., Jonathan Lim, PhD, Gabriel Leprivier, PhD, Marc Remke, MD, Sanil Bhatia, PhD, Thorsten Rosenbaum, MD, Arndt Borkhardt, MD, Ute Fischer, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4651.
https://doi.org/10.1182/blood-2019-131406
Published: 2019
Journal Articles

The Landscape of Circular RNAs in Drug Resistant TCF3 -Rearranged Childhood Leukemia

Cai Chen, Daniel Picard, M.Sc., Nan Qin, PhD, Cyrill Schipp, MSc, Michael Gombert, PhD, Sebastian Ginzel, M.Sc., Jianda Hu, Prof MDPhD, Arndt Borkhardt, Prof MD, Marc Remke, Ute Fischer, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1432.
https://doi.org/10.1182/blood.V130.Suppl_1.1432.1432
Published: 2017